Clinical Trials Sponsored by Marinus Pharmaceuticals
Total 19915 results
-
Vanda PharmaceuticalsRecruitingSleep Disturbances in Smith-Magenis SyndromeUnited States
-
Cumberland PharmaceuticalsRecruitingPathologic Processes | Skin Diseases | Autoimmune Diseases | Connective Tissue Diseases | Scleroderma, Systemic | Scleroderma, Diffuse | Scleroderma, Limited | Sclerosis, Progressive SystemicUnited States, India
-
Alnylam PharmaceuticalsApproved for marketingAcute Hepatic Porphyria
-
Sparrow PharmaceuticalsActive, not recruitingAutonomous Cortisol Secretion (ACS) | ACTH-Independent Cushing Syndrome | ACTH-Independent Adrenal Cushing Syndrome, SomaticUnited States, Romania, United Kingdom
-
Dizal PharmaceuticalsActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, Spain, United States, France, Taiwan, Italy, China, Argentina, Australia, Malaysia, Canada, Japan, Chile
-
Inovio PharmaceuticalsActive, not recruiting
-
Inovio PharmaceuticalsActive, not recruitingUrothelial CarcinomaUnited States
-
Vanda PharmaceuticalsTerminatedAtopic DermatitisUnited States
-
Alnylam PharmaceuticalsActive, not recruitingHypertensionUnited States, Canada, United Kingdom, Puerto Rico, Ukraine
-
Regeneron PharmaceuticalsActive, not recruiting
-
Regeneron PharmaceuticalsActive, not recruitingDiabetic Macular Edema (DME) | Neovascular Age-Related Macular Degeneration (nAMD)United States
-
BioCryst PharmaceuticalsTerminatedParoxysmal Nocturnal Hemoglobinuria | PNHUnited Kingdom, Austria, South Africa
-
Arrowhead PharmaceuticalsActive, not recruitingFamilial ChylomicronemiaKorea, Republic of, Canada, Australia, Singapore, Belgium, Spain, Japan, United States, Austria, Germany, Ireland, Oman, Poland, Israel, New Zealand, Argentina, France, Croatia, Mexico, Serbia, Turkey
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
Regeneron PharmaceuticalsTerminated
-
Aerie PharmaceuticalsCompletedDry Eye DiseaseUnited States
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerUnited States, Korea, Republic of, Chile, Canada
-
Alnylam PharmaceuticalsCompletedAmyloidosis, Familial | Transthyretin AmyloidosisFrance, Germany, Italy, Portugal, Spain, Sweden, United Kingdom
-
Primus PharmaceuticalsWithdrawnDiabetic UlcersUnited States
-
Intercept PharmaceuticalsActive, not recruitingPrimary Biliary CholangitisNetherlands, United Kingdom, Korea, Republic of, Germany, Australia, Estonia, Belgium, France, Czechia, Croatia, Greece, Hungary, Israel, Lithuania, Norway, Poland, Spain
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
Adial PharmaceuticalsCompletedAlcohol Use DisorderBulgaria, Croatia, Estonia, Finland, Latvia, Poland, Sweden
-
Endo PharmaceuticalsTerminatedPeyronie's DiseaseUnited States
-
Regeneron PharmaceuticalsActive, not recruitingVenous ThromboembolismPoland, Latvia, Canada, Belgium, Bulgaria, Hungary, Lithuania
-
Regeneron PharmaceuticalsSuspendedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
Xeris PharmaceuticalsCompletedDiabetes Mellitus, Type 1 | Insulin-dependent Diabetes MellitusUnited States
-
Vanda PharmaceuticalsCompleted
-
Vanda PharmaceuticalsCompletedPerformance AnxietyUnited States
-
Rigel PharmaceuticalsTerminatedImmune Thrombocytopenia | ITPUnited States
-
Regeneron PharmaceuticalsActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Cumberland PharmaceuticalsCompleted
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
BioCryst PharmaceuticalsActive, not recruitingParoxysmal Nocturnal HemoglobinuriaUnited Kingdom, Hungary, France, Spain, Malaysia, South Africa, Korea, Republic of
-
Azurity PharmaceuticalsCompleted
-
Jazz PharmaceuticalsTerminatedSpasticity With Multiple SclerosisSpain, United States, United Kingdom, Czechia, Poland
-
Syros PharmaceuticalsSuspendedAcute Promyelocytic LeukemiaUnited States
-
Longboard PharmaceuticalsCompletedDravet Syndrome | Lennox Gastaut Syndrome | Developmental and Epileptic EncephalopathyUnited States, Australia
-
Alebund PharmaceuticalsCompletedChronic Kidney Diseases | HyperphosphatemiaChina
-
Jazz PharmaceuticalsActive, not recruitingHealthy ParticipantsUnited States
-
Endo PharmaceuticalsCompletedEdematous Fibrosclerotic PanniculopathyUnited States
-
Endo PharmaceuticalsCompletedAcute PainUnited States
-
Endo PharmaceuticalsCompleted
-
Veloxis PharmaceuticalsCompletedHealthy VolunteersUnited States
-
ORIC PharmaceuticalsTerminated
-
Ferring PharmaceuticalsTerminatedControlled Ovarian StimulationDenmark
-
Inovio PharmaceuticalsCompletedRespiratory PapillomatosisUnited States